Obinutuzumab plus standard therapy is efficacious in managing active lupus nephritis
1. In this randomized trial, obinutuzumab plus standard therapy was more efficacious than standard therapy alone in providing a complete ...
Tag: Lupus
Use of hydroxychloroquine may be protective for cardiovascular events in patients with systemic lupus erythematosus
1. In this observational cohort study of patients with systemic lupus erythematosus, the current use of hydroxychloroquine as a treatment ...
Sex differences in mortality among patients with lupus nephritis
1. Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females. Evidence Rating Level: ...
The Scan by 2 Minute Medicine®: One-Stop Shop for Sickle Cell Disease, Lupus and Losing Motherhood, Hurricane Danger and A Tennis Legend Retires:
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. We ...
The Scan by 2 Minute Medicine®: Stroke in Young Patients with Lupus, At-home Cervical Screening, Vaccinated and Acne Free! A Future Possibility, The Rise of a New Synthetic Opioid
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
The 2 Minute Medicine Podcast Episode 2
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The Scan by 2 Minute Medicine®: An Organ Donor Crisis, A Closer Look at Bipolar Disorder, What to know about Processed Foods, and Key Issues in Men’s Health
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Litifilimab associated with reduced disease severity in patients with cutaneous lupus erythematosus
1. Litifilimab significantly decreased cutaneous lupus erythematosus (CLE) disease area and severity index scale (CLASI-A) after 16 weeks of treatment. ...
Oral tacrolimus noninferior to intravenous cyclophosphamide for lupus nephritis
1. Oral tacrolimus was noninferior to intravenous cyclophosphamide for lupus nephritis disease measures with lower toxicity. Evidence Rating Level: 1 ...
Iberdomide elicits SRI-4 response in patients with systemic lupus erythematosus
1. More patients with systemic lupus erythematosus (SLE) who received high doses of iberdomide achieved SRI-4 response compared to placebo ...
